Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6

Cytotechnology

Volumn 63, Issue 5, 2011, Pages 513-521

  Ramadan, Gamal ^a,b  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Ain Shams University   (Egypt)

Author keywords

Adenoviral expression; Interleukin 6; Mo derived fast DCs; T cell proliferation; Tetanus toxoid

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE;

EID: 84655167632     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-011-9375-4     Document Type: Article

References (37)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811 (Pubitemid 30365397)
2. Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, Novarino A, Stacchini A, Bertetto O, Palestro G, Sorio C, Scarpa A, Emanuelli G, Rodeck U (2006) Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol 177:3448-346p (Pubitemid 44277866)
3. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135 (Pubitemid 26306734)
4. Bharadwaj U, Li M, Zhang R, Chen C, Yao Q (2007) Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 67:5479-5488 (Pubitemid 46997289)
5. Blanco P, Palucka AK, Pascual V, Banchereau J (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19:41-52
6. Bohnenkamp HR, Noll T (2003) Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. Cytotechnology 42:121-131 (Pubitemid 38297838)
7. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-787 (Pubitemid 27375158)
8. Cho HI, Kim HJ, Oh ST, Kim TG (2003) In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses. Vaccine 22:224-236
9. Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510-514
10. Dauer M, Obermaier B, Herten J, Haerle C, Pohl K, Rothenfusser S, Schnurr M, Endres S, Eigler A (2003) Mature dendritic cells derived from human monocytes within 48 h: A novel strategy for dendritic cell differentiation from blood precursors. J Immunol 170:4069-4076 (Pubitemid 36428169)
11. Dauer M, Schad K, Herten J, Junkmann J, Bauer C, Kiefl R, Endres S, Eigler A (2005) Fast DC derived from human monocytes within 48 h effectively prime tumor antigenspecific cytotoxic T cells. J Immunol Methods 302: 145-155 (Pubitemid 41111881)
12. Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, Fikrig E, Rincon M (2000) Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13:805-815 (Pubitemid 32041803)
13. Feuerstein B, Berger TG, Maczek C, Roder C, Schreiner D, Hirsch U, Haendle I, Leisgang W, Glaser A, Kuss O, Diepgen TL, Schuler G, Schuler-Thurner B (2000) A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 245:15-29
14. Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG (2001) Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci USA 98:8809-8814 (Pubitemid 32678109)
15. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-2p (Pubitemid 37046923)
16. Hess S, Smola H, Sandaradura De Silva U, Hadaschik D, Kube D, Baldus SE, Flucke U, Pfister H (2000) Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol 165:1939-1948 (Pubitemid 30643145)
17. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serumfree conditions. Eur J Immunol 27:3135-3142 (Pubitemid 28018007)
18. Kalinski P, Schuitemaker JH, Hilkens CM, Kapsenberg ML (1998) Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a?CD83? dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 161:2804-2809 (Pubitemid 28425700)
19. Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH (2001) Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells. Biol Blood Marrow Transpl 7:247-256 (Pubitemid 32591295)
20. Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A (2008) Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA 105: 8357-8362 (Pubitemid 351904760)
21. Lotem M, Zhao Y, Riley J, Hwu P, Morgan RA, Rosenberg SA, Parkhurst MR (2006) Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors. J Immunother 29:616-627 (Pubitemid 44674045)
22. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colonystimulating factor. Blood 92:4778-4791 (Pubitemid 29005881)
23. Mitani H, Katayama N, Araki H, Ohishi K, Kobayashi K, Suzuki H, Nishii K, Masuya M, Yasukawa K, Minami N, Shiku H (2000) Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br J Haematol 109:288-295 (Pubitemid 30350707)
24. Motta JM, Nascimento CR, Rumjanek VM (2010) Leukemic cell products down-regulate human dendritic cell differentiation. Cancer Immunol Immunother 59:1645-1653
25. Obermaier B, Dauer M, Herten J, Schad K, Endres S, Eigler A (2003) Development of a new protocol for 2 day generation of mature dendritic cells from human monocytes. Biol Proced Online 5:197-203 (Pubitemid 38097515)
26. Orsini E, Guarini A, Chiaretti S, Mauro FR, Foa R (2003) The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res 63:4497-4506 (Pubitemid 36951022)
27. Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173:3844-3854 (Pubitemid 39280747)
28. Ramadan G, Konings S, Kurup VP, Keever-Taylor CA (2004) Generation of Aspergillus-and CMV-specific T-cell responses using autologous fast DC. Cytotherapy 6:223-234 (Pubitemid 38868095)
29. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA (2005a) Generation of Th1 T cell responses directed to a HLA class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 139:257-267 (Pubitemid 40222843)
30. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA (2005b) Generation of cytotoxic T cell responses directed to human leucocyte antigen class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol 140:81-91 (Pubitemid 40461076)
31. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480-483 (Pubitemid 28483676)
32. Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, Fogli M, Ferri E, Della Cuna GR, Tura S, Baccarani M, Lemoli RM (2002) Dendritic cells are functionally defective in multiple myeloma: The role of interleukin-6. Blood 100:230-237 (Pubitemid 35177452)
33. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118
34. Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A (2000) Extracellular ATP and TNFalpha synergize in the activation and maturation of human dendritic cells. J Immunol 165:4704-4709
35. Sombroek CC, Stam AG, Masterson AJ, Lougheed SM, Schakel MJ, Meijer CJ, Pinedo HM, van den Eertwegh AJ, Scheper RJ, de Gruijl TD (2002) Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 168:4333-4343 (Pubitemid 34441333)
36. Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 223:1-15 (Pubitemid 29096234)
37. Tian Y, Zhang HH, Wei L, Du SC, Chen HS, Fei R, Liu F (2007) The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes. Viral Immunol 20:553-561